FUS loss in control lung fibroblasts mimics IPF senescence and fibrosis hallmarks
In primary lung fibroblasts, lowering FUS in control cells increased fibrotic and senescence hallmarks resembling IPF cells; in IPF cells, reduced FUS was linked to altered transcription elongation. [1]
Automatic summary · not editorially reviewed
The key findings
The abstract describes IPF as an age-related, lethal lung disease affecting over 3 million people worldwide. [1]
Loss of function of FUS in control fibroblasts enhanced fibrotic and senescence hallmarks resembling IPF fibroblasts. [1]
The abstract proposes that FUS stabilizes R-loops at transcription start sites and acts as a gatekeeper of fibrotic and age-associated transcriptional programs. [1]
The source at a glance
- Study type / format
- Abstract of a multi-omics and functional cell study
- Population / context
- Primary lung fibroblasts from control and IPF patients
- Summary based on
- Study abstract
- Publication status
- Preprint · peer-review status not confirmed
- Original publication
- October 9, 2026
IPF fibroblasts and FUS in an abstract analysis
The abstract describes idiopathic pulmonary fibrosis (IPF) as an age-related, lethal lung disease affecting over 3 million people worldwide. It says the molecular mechanisms behind broad transcriptome changes and senescence in specific cell types of IPF lungs remain sparsely investigated. The work combined multi-omics analyses with functional experiments monitoring fibrotic and senescence hallmarks in primary lung fibroblasts from control and IPF patients.
Supporting source [1]
Reduced FUS in control fibroblasts raised fibrosis and senescence markers
According to the abstract, loss of function of the DNA/RNA-binding protein fused in sarcoma (FUS) in control fibroblasts enhanced fibrotic and senescence hallmarks resembling IPF fibroblasts. In IPF fibroblasts, reduced FUS levels abolished R-loop formation at transcription start sites. This was linked to increased recruitment of RNA polymerase II and its phosphorylation at serine 2, faster translocation of elongating polymerase II and higher expression of fibrosis- and senescence-related genes.
Supporting source [1]
Proposed gatekeeper role of FUS in control fibroblasts
The abstract summarizes that FUS keeps polymerase II processivity low in control fibroblasts by stabilizing R-loops at transcription start sites, acting as a gatekeeper of fibrotic and age-associated transcriptional programs. These are findings from cell experiments and multi-omics analysis, not evidence of effects on human lifespan or disease outcomes. The abstract does not report sample sizes, follow-up or clinical endpoints, and the full text was not reviewed.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. Cell experiments and multi-omics analysis; no sample sizes, follow-up or clinical outcomes are reported. Findings do not establish effects on human lifespan or disease outcomes.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Rogel-Ayala DG, Cordero J, Aguirre-Alarcón HA, Rubio K, Swaminathan G, Charif N, de Isla N, Szymanski W, Kolluru Venkataswamy Reddy G, Braubach P, Mahmood S, Günther S, Rivera MN, Graumann J, Braun T, Wygrecka M, Dobreva G, Barreto G. · europepmc.org · October 9, 2026